doi:10.3969/j.issn.1004-583X.2026.01.013

Abstract

CLC Number:

R654.1

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2026.01.013

https://www.lchc.cn/EN/Y2026/V41/I1/73

References 36

[1]	刘明波, 何新叶, 杨晓红, 等. 中国心血管健康与疾病报告2023》概要(心血管疾病流行及介入诊疗状况)[J]. 中国介入心脏病学杂志, 2024, 32(10):541-550.doi: 10.3969/j.issn.1004-8812.2024.10.001.
[2]	Zhou ZF, Wang DJ, Li XM, et al. Effects of enhanced external counterpulsation on exercise capacity and quality of life in patients with chronic heart failure: A meta-analysis[J]. Medicine (Baltimore). 2021, 100(27):e26536. doi: 10.1097/MD.0000000000026536.
[3]	黄雯婷, 张茹欣, 王京, 等. 体外反搏对高血压患者的影响[J]. 中华高血压杂志(中英文), 2025, 33(4):385-388. doi:10.16439/j.issn.1673-7245.2025.04.013.
[4]	Qin X, Deng Y, Wu D, et al. Does enhanced external counterpulsation (EECP) significantly affect myocardial perfusion?: A systematic review & meta-analysis[J]. PLoS One, 2016, 11(4):e0151822. doi: 10.1371/journal.pone.0151822.
[5]	Lishuta AS, Slepova OA, Nikolaeva NA, et al. Cardiovascular effects of long-term treatment with enhanced external counterpulsation in patients with ischemic heart failure: Randomized, placebo-controlled, open-label clinical trial[J]. J Cardiovasc Dev Dis, 2025, 12(9):352.doi: 10.3390/jcdd12090352.
[6]	Lin S, Xiao-Ming W, Gui-Fu W. Expert consensus on the clinical application of enhanced external counterpulsation in elderly people (2019),[J]. Aging Med (Milton), 2020, 3(1):16-24. doi: 10.1002/agm2.12097.
[7]	Xu L, Cui M, Zhao W. The effect of EECP on ischemic heart failure: A systematic review[J]. Curr Cardiol Rep, 2023, 25(10):1291-1298. doi: 10.1007/s11886-023-01943-1.
[8]	Sahebjami F, Madani FR, Komasi S, et al. Refractory angina frequencies during 7 weeks treatment by enhanced external counterpulsation in coronary artery disease patients with and without diabetes[J]. Ann Card Anaesth, 2019, 22(3):278-282. doi: 10.4103/aca.ACA_86_18.
[9]	Zhang Y, Yin X, Ren L. A randomized controlled study of enhanced external counterpulsation with cardiac rehabilitation in patients with nonobstructive coronary artery disease and coronary microvascular dysfunction[J]. Int Heart J, 2024, 65(3):380-385. doi: 10.1536/ihj.23-454.
[10]	Ashokprabhu ND, Fox J, Henry TD, et al. Enhanced external counterpulsation for the treatment of angina with nonobstructive coronary artery disease[J]. Am J Cardiol, 2024, 211:89-93. doi: 10.1016/j.amjcard.2023.10.061.
[11]	Liang J, Shi J, Wei W, et al. External Counterpulsation attenuates hypertensive vascular injury through enhancing the function of endothelial progenitor cells[J]. Front Physiol, 2021, 11:590585. doi: 10.3389/fphys.2020.590585.
[12]	张丹丹, 王少华, 马娟, 等. 增强型体外反搏对老年高血压患者血压的即刻作用和持续影响[J]. 中华老年医学杂志, 2021, 40(12):1512-1515. doi: 10.3760/cma.j.issn.0254-9026.2021.12.008.
[13]	Picard F, Panagiotidou P, Wolf-Pütz A, et al. Individual shear rate therapy (ISRT)-further development of external counterpulsation for decreasing blood pressure in patients with symptomatic coronary artery disease (CAD)[J]. Hypertens Res, 2020, 43(3):186-196. doi: 10.1038/s41440-019-0380-x.
[14]	Duan Y, Tang HX. Efficacy of enhanced extracorporeal counterpulsation combined with atorvastatin in the treatment of cognitive impairment after stroke[J]. World J Psychiatry, 2023, 13(12):1027-1036. doi: 10.5498/wjp.v13.i12.1027.
[15]	Li B, Wang W, Mao B, et al. Hemodynamic effects of enhanced external counterpulsation on cerebral arteries: A multiscale study[J]. Biomed Eng Online, 2019, 18(1):91. doi: 10.1186/s12938-019-0710-x.
[16]	Huang J, Liang M, Jiang D, et al. Enhanced Parkinson's gait, reduced fall risk, and improved cognitive function through multimodal rehabilitation combined with rivastigmine treatment[J]. Am J Transl Res, 2024, 16(6):2379-2388. doi: 10.62347/PAXI7650.
[17]	Yang W, Lu L, Cheng J, He X. Research focus and theme evolution on enhanced external counterpulsation: A bibliometric analysis[J]. Heliyon, 2024, 11(1):e41258. doi: 10.1016/j.heliyon.2024.e41258.doi:10.1016/j.heliyon.2024.e41258.
[18]	李淑妍, 陶新宇, 曲晨. 血管壁面剪切应力对动脉粥样硬化和动脉瘤的影响[J]. 中国动脉硬化杂志, 2024, 32(5):451-455.doi:10.20039/j.cnki.1007-3949.2024.05.012.
[19]	Zhou M, Yu Y, Chen R. Wall shear stress and its role in atherosclerosis[J]. Front Cardiovasc Med, 2023, 10:1083547. doi: 10.3389/fcvm.2023.1083547.
[20]	Gurovich AN, Braith RW. Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans[J]. Hypertens Res, 2013, 36(4):297-305. doi: 10.1038/hr.2012.169. Epub 2012 Oct 18.
[21]	Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, et al. Endothelial dysfunction, inflammation and coronary artery disease: Potential biomarkers and promising therapeutical approaches[J]. Int J Mol Sci, 2021, 22(8):3850. doi: 10.3390/ijms22083850.
[22]	Braith RW, Conti CR, Nichols WW, et al. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: A randomized sham-controlled study[J]. Circulation, 2010, 122(16):1612-20.doi: 10.1161/CIRCULATIONAHA.109.923482. Epub 2010 Oct 4.
[23]	Yin Q, Jiang H, Zhang Z, et al. Influence of enhanced external counterpulsation on endothelial function: A meta-analysis of randomized controlled trials[J]. Scand Cardiovasc J, 2023, 57(1):2273223. doi: 10.1080/14017431.2023.2273223.
[24]	刘全未, 赵增光, 霍雨佳, 等. 增强型体外反搏对冠状动脉慢血流患者脉搏波传导速度及内皮功能的影响[J]. 心肺血管病杂志, 2019, 38(7):721-724.
[25]	Buschmann EE, Brix M, Li L, et al. Adaptation of external counterpulsation based on individual shear rate therapy improves endothelial function and claudication distance in peripheral artery disease[J]. Vasa, 2016, 45(4):317-24. doi: 10.1024/0301-1526/a000544.
[26]	Caceres J, Atal P, Arora R, et al. Enhanced external counterpulsation: A unique treatment for the “No-Option” refractory angina patient[J]. J Clin Pharm Ther, 2021, 46(2):295-303. doi: 10.1111/jcpt.13330. Epub 2021 Jan 7.
[27]	钱孝贤, 陈燕铭, 吴伟康, 等. 体外反搏对心肌缺血犬SOD和MDA的影响[J]. 中山大学学报(医学科学版), 2006, ( S2):9-11. doi:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2006.0284.
[28]	Shaker SR, Al-Amran F, Fatima G, et al. Trimetazidine improves the outcome of EECP therapy in patients with refractory angina pectoris[J]. Med Arch, 2020, 74(3):199-204. doi: 10.5455/medarh.2020.74.199-204.
[29]	Sardina PD, Martin JS, Dzieza WK, et al. Enhanced external counterpulsation (EECP) decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment[J]. Acta Diabetol, 2016, 53(5):753-60. doi: 10.1007/s00592-016-0869-6.
[30]	Luo JY, Wu GF, Xiong Y, et al. Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia[J]. Chin Med J (Engl), 2009, 122(10):1188-1194.
[31]	Zhang Y, Yin X, Ren L. A randomized controlled study of enhanced external counterpulsation with cardiac rehabilitation in patients with nonobstructive coronary artery disease and coronary microvascular dysfunction[J]. Int Heart J, 2024, 65(3):380-385. doi: 10.1536/ihj.23-454.
[32]	Malhotra R, Bakken K, D'Elia E, et al. Cardiopulmonary exercise testing in heart failure[J]. JACC Heart Fail, 2016, 4(8):607-616. doi: 10.1016/j.jchf.2016.03.022.
[33]	Prasad M, Corban MT, Henry TD, et al. Promise of autologous CD34+ stem/progenitor cell therapy for treatment of cardiovascular disease[J]. Cardiovasc Res, 2020, 116(8):1424-1433. doi: 10.1093/cvr/cvaa027.
[34]	Raza A, Steinberg K, Tartaglia J, et al. Enhanced external counterpulsation therapy: Past, present, and future[J]. Cardiol Rev, 2017, 25(2):59-67. doi: 10.1097/CRD.0000000000000122.
[35]	Tartaglia JT, Eisenberg CA, DeMarco JC, et al. Mobilization of endogenous CD34+/CD133+ endothelial progenitor cells by enhanced external counter pulsation for treatment of refractory angina[J]. Int J Mol Sci, 2024, 25(18):10030. doi: 10.3390/ijms251810030.
[36]	Velagapudi P, Turagam M, Kolte D, et al. Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials[J]. Cardiovasc Revasc Med, 2019, 20(3):215-219. doi: 10.1016/j.carrev.2018.05.018.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 36

Related Articles 5

Recommended Articles

Metrics

Comments

[1]	Ma Qin, Wang Zhiwei, Ma Jing, Zhang Li. Characteristics and influencing factors of respiratory device-related pressure injury in patients underwent cardiopulmonary bypass [J]. Clinical Focus, 2025, 40(3): 231-236.
[2]	Wang Ying, Zhong Bohua, Wang Lifang, Lang Qiuyan, Luo Haibin, Wang Shulin, Li Chunpeng, Liao Min. Epidemiological characteristics of hospital-acquired infections in pediatric patients supported by extracorporeal membrane oxygenation: A meta-analysis [J]. Clinical Focus, 2025, 40(1): 14-20.
[3]	Li Guanzhu, Yang Yating, Deng Jinhe, Shao Lan, Zeng Chaokun. Effects of pituitrin combined with epinephrine in cardiopulmonary resuscitation: A meta-analysis [J]. Clinical Focus, 2024, 39(3): 208-215.
[4]	Peng Yimeng, Yao Yang, Li Siyu, Ding Ge, Sun Yanan, Wang Shengyu. Meta-analysis of the incidence of extracorporeal membrane oxygenation combined with incident thrombosis [J]. Clinical Focus, 2024, 39(1): 5-11.
[5]	Wang Jianli, Li Weiyi, Zhao Guangbin, Fan Lijun. Efficacy of cardiopulmonary resuscitation training mode: From tertiary hospital to community health service center then to community residents [J]. Clinical Focus, 2022, 37(9): 796-798.